Welcome to our dedicated page for Hyperion DeFi SEC filings (Ticker: HYPD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hyperion DeFi, Inc. (NASDAQ: HYPD) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered tools to help interpret them. Hyperion DeFi’s filings describe its evolution from an ophthalmic technology company into a Hyperliquid-native DeFi business that builds and deploys a long-term strategic treasury of HYPE, the native token of the Hyperliquid blockchain, while continuing development of its Optejet User Filled Device.
Investors can review Form 8-K current reports that detail material events such as at-the-market equity program amendments, Sales Agreements with investment banks, HAUS agreements with DeFi partners, and the Joint Validator Operators’ Agreement for the Kinetiq × Hyperion validator node. Other 8-K filings describe leadership changes, including appointments of key executives, and press releases furnishing quarterly financial results and investor presentations.
Annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) typically provide a broader view of Hyperion DeFi’s business model, including its digital asset treasury strategy, revenue components such as staking rewards, validator commissions, yield enhancement, DeFi monetization, and ecosystem rewards, as well as its ongoing life sciences activities around the Optejet User Filled Device. Proxy statements on Schedule 14A can offer additional detail on governance, board composition, and executive compensation.
On Stock Titan, these filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI-powered summaries highlight key points from lengthy documents, helping readers understand how new agreements, capital raises, or digital asset strategies may affect Hyperion DeFi’s operations and risk profile. Users can also review Form 4 insider transaction reports to see how directors and officers are trading HYPD shares, and use AI explanations to interpret complex disclosures without wading through full-text filings.
Insider grant and ownership update: On 08/18/2025 Hyunsu Jung, a director and Chief Investment Officer of Hyperion DeFi, Inc. (HYPD), was granted 1,000,000 shares of common stock at a reported price of $0. The Form 4 shows Jung beneficially owns 1,500,000 shares following the reported transaction. The grant is performance-contingent: 500,000 shares vest if the issuer reaches a market capitalization of $150,000,000 and the remaining 500,000 shares vest if market capitalization reaches $500,000,000.
Rachel Jacobson, a director of Hyperion DeFi, Inc. (HYPD), was granted 50,000 restricted stock units (RSUs) on 08/18/2025. The RSUs are non‑cash awards that vest in three tranches: 25,000 on December 15, 2025; 12,500 on May 26, 2026; and 12,500 on August 16, 2026. All RSUs will vest immediately if a defined Corporate Transaction occurs or if Ms. Jacobson’s board service ends for any reason other than her voluntary resignation. After the grant, Ms. Jacobson beneficially owns 56,301 shares. The filing is a Form 4 disclosure signed and dated 08/20/2025.
Ellen R. Strahlman, a director of Hyperion DeFi, Inc. (HYPD), received an award of 50,000 restricted stock units (RSUs) on 08/18/2025 at no cash price. After the grant, she beneficially owns 56,706 shares. The RSUs vest in three tranches: 25,000 on 12/15/2025, 12,500 on 05/26/2026 and 12,500 on 08/16/2026.
The award also contains acceleration provisions: all RSUs vest immediately upon a defined Corporate Transaction or if her board service ends for reasons other than her voluntary resignation. The Form 4 was signed by Ms. Strahlman on 08/20/2025.
Michael S. Geltzeiler, a director of Hyperion DeFi, Inc. (HYPD), received 50,000 restricted stock units (RSUs) on 08/18/2025 at no cash price. The RSUs are recorded as non‑derivative equity awards and leave the reporting person with 58,015 shares beneficially owned after the grant. The RSUs vest in three tranches: 25,000 on December 15, 2025; 12,500 on May 26, 2026; and 12,500 on August 16, 2026. The awards also vest immediately in full upon a defined Corporate Transaction or if the director’s service ends for any reason other than a self‑initiated resignation. This Form 4 was signed by the reporting person on 08/20/2025.
Hyperion DeFi, Inc. (HYPD) has set its virtual 2025 AGM for 18 Aug 25 and is asking shareholders to vote on nine proposals. Besides re-electing the five-member board and ratifying newly appointed auditor CBIZ CPAs (which replaced Marcum on 2 May 25 with no reported disagreements), investors will give an advisory say-on-pay and decide on several capital structure and governance changes.
Dilution is the central issue. Management seeks to double authorized common shares to 600 M and raise preferred authorization from 6 M to 60 M, even though only 5.6 M common are outstanding and about 50.4 M are already reserved for convertibles, warrants and equity plans. It also proposes adding 5.17 M shares to the 2018 Omnibus Stock Incentive Plan (total 5.61 M) and removing the $150 k annual limit on non-employee director equity, materially expanding share-based compensation capacity. A separate item would approve issuance of 394,236 shares tied to an inducement warrant.
Governance amendments include allowing shareholder action by written consent and authorizing adjournment if Proposals 4, 5 or 7 lack votes. The filing reminds investors that previous audits contained going-concern language and two material weaknesses remain under remediation. The board unanimously recommends voting FOR all proposals.
FAQ
What is the current stock price of Hyperion DeFi (HYPD)?
What is the market cap of Hyperion DeFi (HYPD)?
